Possible Involvement of 5-HT4 Receptors, in Addition to 5-HT3 Receptors, in the Emesis Induced by High-Dose Cisplatin in Suncus murinus

Joss, 1990, The symptomatic control of cytostatic drug-induced emesis. A recent history and review, Eur J Cancer 26 Suppl, 1, S2 Costall, 1986, 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis, Neuropharmacology, 25, 959, 10.1016/0028-3908(86)90030-4 Miner, 1986, Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism, Br J Pharmacol, 88, 497, 10.1111/j.1476-5381.1986.tb10228.x Hawthorn, 1988, The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret, Q J Exp Physiol, 73, 7, 10.1113/expphysiol.1988.sp003124 Turconi, 1991, Pharmacological propaties of a novel class of 5-HT3 receptor antagonists, Eur J Pharmacol, 203, 203, 10.1016/0014-2999(91)90716-4 Torii, 1991, Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus, Jpn J Pharmacol, 55, 107, 10.1254/jjp.55.107 Ito, 1995, The anti-emetic activity of GK-128 in Suncus murinus, Eur J Pharmacol, 285, 37, 10.1016/0014-2999(95)00372-R Gregory, 1998, 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting, Drugs, 55, 173, 10.2165/00003495-199855020-00002 Fukui, 1994, Possible involvement of peripheral 5-HT4 receptors in copper sulfate-induced vomiting in dogs, Eur J Pharmacol, 257, 47, 10.1016/0014-2999(94)90692-0 Yamakuni, 2000, Probable involvement of the 5-hydroxytryptamine4 receptor in methotrexate-induced delayed emesis in dogs, J Pharmacol Exp Ther, 292, 1002 Bhandari, 1991, Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulfate-induced vomiting in the ferret, Eur J Pharmacol, 204, 273, 10.1016/0014-2999(91)90852-H Schiavi, 1994, Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding, Neuropharmacology, 33, 543, 10.1016/0028-3908(94)90085-X Grossman, 1993, Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain, Br J Pharmacol, 109, 618, 10.1111/j.1476-5381.1993.tb13617.x Van Wijngaarden, 1990, The concept of selectivity in 5-HT receptor research, Eur J Pharmacol, 188, 301, 10.1016/0922-4106(90)90190-9 Minami, 1995, Toxicological aspects of cisplatin-induced emesis with emphasis on serotonin release, J Toxicol Sci, 20, 77, 10.2131/jts.20.4_App77 Tyers, 1992, Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists, Oncology, 49, 263, 10.1159/000227054 Minami, 1995, Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine, Res Commun Mol Pathol Pharmacol, 89, 131 Gebauer, 1993, Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea pig small intestine, Naunyn Schmiedebergs Arch Pharmacol, 347, 137, 10.1007/BF00169258 Schwörer, 1998, Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro, Naunyn Schmiedebergs Arch Pharmacol, 357, 548, 10.1007/PL00005206 Perry, 1998, Sumatriptan. An updated review of its use in migraine, Drugs, 55, 889, 10.2165/00003495-199855060-00020 Hikasa, 1992, Alpha adrenoceptor subtypes involved in the emetic action in dogs, J Pharmacol Exp Ther, 261, 746